- This event has passed.
Advances in Precision and Personalized Medicine Workshop
March 14, 2019 @ 4:00 am - March 15, 2019 @ 9:00 am
** Deadline for applications for this workshop was January 30, 2019
Location
This workshop will be held at SAS Hall on the campus of NC State University.
Description
This workshop seeks to bring together experts in industry, academia, and regulatory affairs to discuss current advances and future goals in the field of precision medicine. In alignment with SAMSI’s year-long Program on Statistical, Mathematical, and Computational Methods for Precision Medicine (PMED), our speakers will range in topics from hospital care and workflow, pharmaceutical development, observational and real-world evidence, and regulatory developments.
The conference will feature world-leading presenters from industry, regulatory, and academia. Our speakers will cover a range of healthcare industries including hospitals, home care, insurance, Big Pharma, CROs, biotech, and mobile health.
The workshop will feature two round-table discussions:
-
- Lessons and Challenges in Observational Health Data: A round-table debate on the work generated by the Observed Medical Outcomes Partnership (OMOP) and the Observational Health Data Sciences and Informatics program (OHDSI). The panel will be led by Rosa Gini (Agenzia regionale di sanità della Toscana, Florence, Italy), Miguel Hernan (Harvard), David Madigan (Columbia University), and Marc Suchard (UCLA).
- Regulatory Advancements in the FDA: A panel discussion about recent developments in the FDA’s Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER). The panel will be led by Telba Irony (FDA CBER).
The workshop will also feature a presentation speed-session for researchers to introduce their work. Confirmed speakers for this event include:
- Demissie Alemayehu (Columbia University)
- David Banks (SAMSI Director and Duke University)
- Jason Burke (UNC Healthcare)
- Glen Wright Colopy (Current Health and Oxford University)
- Rachel DiSantostefano (Johnson & Johnson)
- Lauren Drinkard (Lumeris)
- Jessilyn Dunn (Duke University)
- Madalina Fiterau (University of Massachusetts – Amherst)
- Jeff Fuller (UNC Health)
- Patrick Getzen (Blue Cross, Blue Shield-NC)
- Rosa Gini (Agenzia regionale di sanità della Toscana, Florence, Italy)
- Sophie Guo (Deep6 AI)
- Boris Hayete (GNS Healthcare)
- Miguel Hernan (Harvard T.H. Chan School of Public Health)
- Martin Ho (FDA CBER)
- Telba Irony (FDA CBER)
- Alistair Johnson (MIT)
- Dukka B. Kc (NC A&T State University)
- Warren Kibbe (Duke University)
- Rebecca Krouse (Rho)
- Lisa LaVange (University of North Carolina at Chapel Hill)
- Ilya Lipkovich (Senior Research Advisor at Eli Lilly, Real World Analytics)
- David Madigan (Statistics Department, Columbia University)
- Carol Mansfield (RTI Health Solutions)
- Christopher McCann (Current Health)
- Jeff Painter (JiveCast)
- West Paul (WakeMed)
- Paolo Piraino (Bayer AG)
- Russell Reeve (Senior Director of Advisory Analytics, IQVIA)
- Estelle Russek-Cohen (FDA CBER)
- John Scott (FDA CBER)
- Xiling Shen (Duke University)
- Marc Suchard (Departments of Biomathematics and of Human Genetics, David Geffen School of Medicine, UCLA)
- Benjamin Villard (Oxford and University of Nagoya)
- Brian K. Walsh (Liberty University)
- Herb Weisberg (Causalytics, LLC)
- Richard Zink (Senior Director of Data Management and Statistics, TARGET PharmaSolutions)